# MobiDabet: Mobile Telemonitoring System for Patients with Type 2 Diabetes Mellitus (T2 DM)
## 5 Discussion  
Some works [5; 6; 7; 8; 9; 10; 11; 12; 13] have proposed systems aimed at monitoring and treatment of people with type 2 diabetes mellitus (T2 DM). These systems provide different services focused on the telemonitoring of patients with T2 DM. Therefore, this section presents a qualitative comparison of our system with other proposed systems based on the desirable services that a telemonitoring system for patients with T2 DM should consider for achieving adequate remote monitoring and control (see Table 12). These comparison services were determined based on the analysis of the Official Mexican Standard NOM-015-SSA2-2018 focused on the prevention, detection, diagnosis, treatment, and control of diabetes mellitus, giving priority to the processes and/or information that contributed to reduce the incidence of \begin{table}
\begin{tabular}{c c c c} \hline \hline
**Position** & **Attribute** & **Average Score** & **Total Score** \\ \hline
1 & Presentation & 4.1 & \\
2 & Content & 4.0 & 4.0 \\
3 & Navigation & 3.9 & \\ \hline \hline \end{tabular}
\end{table} 
Table 10: Results of Instrument 3, physician profile. \begin{table}
\begin{tabular}{c c c c} \hline \hline \multirow{2}{*}{**Evaluator**} & \multicolumn{3}{c}{**Percentages of Each Evaluated Profile**} \\ \cline{2-4}  & **Physician** & **Nutritionist** & **Patient** \\ \hline Evaluator 1 & 82.61\% & 82.61\% & 81.16\% \\ Evaluator 2 & 85.90\% & 85.90\% & 85.07\% \\ Evaluator 3 & 79.03\% & 79.03\% & 84.20\% \\ Mean & 82.51\% & 82.51\% & 83.48\% \\ \hline \hline \end{tabular}
\end{table} 
Table 11: Results of the SIRIUS heuristic evaluation the disease, to avoid or delay its complications, and reduce the mortality associated with this disease. These services are specified below:  
* Registration of biomedical data by the patient (PR): Consultation and registration of different biomedical data relevant for monitoring and control of treatment
* Consultation of information by the physician (CD): Access to relevant patient information in real-time for the monitoring and control of patients with T2 DM. * Clinical history (CH): Record the patient's medical history, which should include personal data of the patient and medical history. * Alert generation (AG): Generation of alerts indicating that the patient is at some risk based on the biomedical parameters recorded. * Laboratory analysis record (LR): The record of the results of the laboratory tests requested of the patient, such as blood chemistry test, complete blood count, general urine test, liver function test, and thyroid profile test. * Nutrition (N): Have personalized nutritional menus and options for equivalent foods. This service brings the patient the benefit of knowing what foods and in what quantity they can substitute, in case of not having those established in the menu. * Health education (HE): Help material is provided with topics related to diabetes, and the care that patients should have. In order to achieve the adoption of habits that help avoid health complications. * Recommendations (R): The medical specialist and nutritionist can make suggestions to the patient for their health care. Based on the analysis shown in Table 12, the proposed systems lack three main elements to carry out adequate monitoring and remote treatment of people with T2 DM. First, the systems lack a recommendation service for physicians and nutritionists, which is essential to make timely adjustments to treatment and avoid possible risk situations. Second, in the proposed systems that consider a nutrition service, there is a lack of menus and eating patterns prepared by specialists and assigned according to the calories regarding the patient progress. Finally, they do not provide educational material with issues related to awareness and prevention of possible health complications. In this qualitative comparison, it is noted that the work proposed in VITADAT Diabetes meets various desirable criteria of a telemonitoring system for patients with T2 DM.